[Pharmacological correction of the disorders of cardiac contractile function in stress].
It has been established that sodium hydroxybutyrate, prolactin, propranolol and ionol are capable of preventing the depression of the contractile function of the heart and of decreasing the glycogen level in the myocardium, provoked by emotional stress.
D000818:Animals; D002084:Butylated Hydroxytoluene / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006003:Glycogen / Q000378:metabolism; D006331:Heart Diseases / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism; D011388:Prolactin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D051381:Rats; D012978:Sodium Oxybate / Q000627:therapeutic use; D013315:Stress, Psychological / Q000150:complications* / Q000503:physiopathology
D002084:Butylated Hydroxytoluene; D012978:Sodium Oxybate; D011388:Prolactin; D006003:Glycogen; D011433:Propranolol
Farmakologicheskaia korrektsiia narusheniĭ sokratitel'noĭ funktsii serdtsa pri stresse.